Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300053
- Awardee
-
New England Biolabs, Inc. UEI EDKJNT8DADG8
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,795
Award facts
- Contract value 100% obligated
- $3,795.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Ipswich, MA 01938, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was made by the Office of the Director, a civilian agency, to New England Biolabs, Inc., a for-profit manufacturer of molecular biology products. The $3,795 Blanket Purchase Agreement (BPA) call order was issued on May 15, 2013, with a completion date of December 31, 2013. The contract was for the delivery of "DRUGS AND BIOLOGICALS" and did not have a set-aside designation.
New England Biolabs is a leading supplier of specialized reagents, kits, and enzymes for life sciences research, particularly in the areas of genomics, infectious disease research, and molecular biology. The company has a long history of providing these critical research tools to various institutes within the National Institutes of Health (NIH), including the National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), among others. In addition to this BPA contract, New England Biolabs holds a larger $10 million BPA with the NIH Office of Logistics and Acquisition Operations, which allows NIH components to efficiently procure the company's products for their biomedical research needs.
Quick answers
Who was awarded contract HHSN26300053?
HHSN26300053 was awarded to New England Biolabs, Inc. by Office of the Director (National Institutes of Health) on May 15, 2013.
How much is contract HHSN26300053 worth?
The government has obligated $3,795 on HHSN26300053.
Is contract HHSN26300053 an order under another contract?
Yes. HHSN26300053 is a BPA call under HHSN263201100018B, a blanket purchase agreement.
Was contract HHSN26300053 competed?
The extent of competition for HHSN26300053 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award